Interferon Alpha Can Delay Full Onset Of Type I Diabetes, Phase II Trial Suggests
Wednesday, July 1, 2009 - 08:35
in Health & Medicine
A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes, according to the results of a Phase II trial.